Infusion of transforming growth factor ␣ (TGF␣) into the adult dopamine (DA)-depleted striatum generates a local population of nestin ؉ /proliferating cell nuclear antigen (PCNA) ؉ newborn cells. The precise origin and fate of these new striatal cells are unknown, making it difficult to direct them for neural repair in Parkinson's disease. Experiments in rats using 5-bromo-2-deoxyuridine (BrdU) to label neural progenitor cells showed that during TGF␣ infusion in the DA-depleted striatum, newborn striatal cells formed a homogeneous population of precursors, with the majority coexpressing nestin, Mash1, Olig2, and epidermal growth factor receptor, consistent with the phenotype of multipotent C cells. Upon TGF␣ pump withdrawal, the subventricular zone (SVZ) was repopulated by neuroblasts. Strikingly, during this period, numerous clusters of doublecortin ؉ /polysialylated neuronal cell adhesion molecule ؉ neuroblasts were also produced in the ipsilateral medial striatum. In parallel, striatal BrdU ؉ /glial fibrillary acidic protein ؉ astrocytes were generated, but no BrdU ؉ /O4 ؉ /CNPase ؉ oligodendrocytes were generated. Infusion of the neuralizing bone morphogenetic protein antagonist noggin after TGF␣ pump withdrawal increased the neuroblast-to-astrocyte ratio among new striatal cells by blocking glial differentiation but did not alter striatal neurogenesis. At no time or treatment condition were differentiated neurons generated, including DA neurons. Using 6-hydroxydopamine-lesioned nestin-Cre-ER T2 /R26R-YFP mice that allow genetic fate-mapping of SVZ nestin ؉ cells, we show that TGF␣-generated striatal cells originate from SVZ nestin ؉ precursors that confirmed data from the rats on the phenotype and fate of striatal nestin ؉ /PCNA ؉ cells upon TGF␣ withdrawal. This work demonstrates that a large population of multipotent striatal C-like cells can be generated in the DAdepleted striatum that do not spontaneously differentiate into DA neurons.
INTRODUCTION
In the context of Parkinson's disease (PD), subventricular zone (SVZ) neural stem and precursor cells (herein collectively called neural progenitor cells [NPCs] ) do not contribute to dopamine (DA) cell replacement [1] . The SVZ is the largest neurogenic zone in the brain and is adjacent to the striatum, the region where most DA neurotransmitter depletion occurs in PD. Given that some SVZ cells continuously differentiate into olfactory bulb (OB) DA neurons throughout life, their artificial recruitment into the striatum and differentiation into DA neurons is an appealing alternative to transplantation therapies [2] [3] [4] .
The cytoarchitecture, cellular composition, and lineage relationships between different NPC subtypes in the mammalian SVZ have been extensively studied [5] [6] [7] [8] . There are three well-characterized NPC subtypes in the adult SVZ. The primary precursors, which are thought to be neural stem cells (B cells), have immunocytochemical and ultrastructural characteristics of astrocytes [7] . These SVZ astrocytes give rise to transit-amplifying precursor cells (C cells), which have a globular morphology and proliferate rapidly, thus increasing the size of the SVZ precursor pool. The C cells generate neuroblasts (A cells) that express the polysialylated neuronal cell adhesion molecule (PSANCAM) and doublecortin (DCX) [7] . Those neuroblasts are committed to the neuronal lineage and migrate toward the OB, where they ultimately differentiate into interneurons, which use GABA or both GABA and DA as neurotransmitters. The latter interneurons constitute the A16 population of DA neurons; these neurons share functional characteristics with A9 DA neurons [9, 10] . Finally, in addition to OB neurons, some SVZ B cells generate oligodendrocytes, although the precise lineage leading to this fate is unclear [11] .
DA secreted by midbrain afferent projections promotes NPC proliferation in the SVZ by binding directly to D2-like receptors on C cells [1] . Probably as a direct consequence of this, animal models of PD [1, 12] and PD patients [1] display reduced SVZ cell proliferation and fewer newborn OB neurons [1] . Surprisingly, SVZ Pax6 ϩ DA neuron precursors and olfactory bulb DA neurons are increased in PD animal models [13] [14] [15] . This provides the intriguing possibility of using chemoattractants or growth factors to artificially recruit endogenous DA neuron precursors to the DA-depleted striatum.
In the 6-hydroxydopamine (6-OHDA) rodent model of PD, striatal transforming growth factor ␣ (TGF␣) infusion stimulates forebrain cell division and induces septal and striatal waves of nestin ϩ /proliferating cell nuclear antigen (PCNA) ϩ cells oriented toward the infusion cannula [2, 16] . Here we infused the epidermal growth factor receptor (EGFR) agonist TGF␣ into the DA-depleted striatum [2, 16] and addressed the following new questions: (a) what are the origin and phenotype(s) of TGF␣-activated cells in the striatal wave? (b) What is their fate 2 weeks after TGF␣ withdrawal? (c) What is the effect of TGF␣ and noggin consecutive infusions, given the known neurogenic influence of noggin on SVZ cells [17] ?
MATERIALS AND METHODS

Rats
Adult 250 -300-g female Sprague-Dawley rats (Taconic Farms, Germantown, NY, http://www.taconic.com) were administered 6-OHDA in the medial forebrain bundle [18] (n ϭ 88, eight per group for all groups, except n ϭ 4 for TGF␣ 2 weeks/phosphate-buffered saline [PBS] 4 weeks). The animals were maintained in accordance with current NIH guidelines and McLean Hospital/Harvard University Institutional Animal Care and Use Committee protocols.
TGF␣ and Noggin Infusions in Rats
The infusion procedures for TGF␣ and noggin were performed as described [2] . Osmotic pumps (models 1002 and 2004; Alzet Osmotic Pumps, Cupertino, CA, http://www.alzet.com) delivered either (a) 0.5 mg/ml TGF␣ (R&D Systems Inc., Minneapolis, http://www. rndsystems.com), (b) 6 g/ml noggin (R&D Systems), (c) 0.5 mg/ml TGF␣ and 6 g/ml noggin, or (d) PBS into the right striatum (ϩ1.2 Anterior/Posterior (A/P); ϩ2.7 Medical/Lateral (M/L) via a cannula (Brain Infusion Kit II; Alzet Osmotic Pumps) at 0.25 l h
Ϫ1
. Proteins were dissolved in 0.1 M PBS. For sequential infusions, rats were anesthetized, and the osmotic pump was replaced while the cannula, polyethylene tubing, and flow moderator remained in place.
Nestin-CreER
T2 /R26R-YFP Mouse Experiments
Five-to 8-week-old nestin-CreER T2 /R26R-YFP mice [19] were anesthetized with ketamine/xylazine solution, and 6-OHDA (5.0 mg/ml in 0.9% NaCl/0.02% ascorbate) was injected by microliter syringe (Hamilton Co., Reno, NV, http://www.hamiltoncompany.com) at 0.5 l/ minute by pump for a total dose of 15.0 mg/3 l. The right striatum was targeted at the following stereotaxic coordinates: A/P, ϩ0.9 mm; M/L, ϩ2.2 mm; Dorsal/Ventral (D/V), Ϫ2.5 mm relative to bregma [20] . Two weeks following 6-OHDA injection, mice were administered tamoxifen at 180 mg/kg per day for 5 days (intraperitoneally [i.p.]; dissolved in 10% ethanol/90% sunflower oil). The first group of mice was sacrificed 2 days after the tamoxifen regimen (Fig. 1C1) . For the other two groups, 1 week following the tamoxifen regimen, osmotic pumps delivered either 0.5 mg/ml TGF␣ or 0.9% saline into the right striatum (A/P, ϩ1 mm; M/L, ϩ1.3 mm; D/V, Ϫ3 mm relative to bregma). Mice were sacrificed after 2 weeks of infusion (Fig. 1C2 ) or 2 weeks after pump withdrawal (Fig. 1C3 ).
5-Bromo-2-Deoxyuridine Administration
Rats were administered 5-bromo-2Ј-deoxyuridine (BrdU) (SigmaAldrich, St. Louis, http://www.sigmaaldrich.com) i.p. once per day from days 3-14 of the first TGF␣/PBS infusion at a dose of 50 mg/kg body weight (Fig. 1B) . We waited 3 days after pump im- BrdU was administered daily during the first 2 weeks of infusion (shown in red). Adult 6-OHDA-lesioned rats were sacrificed either on day 14 during TGF␣ or PBS infusion (B1); on day 28 after infusion of the second agent (PBS or noggin) for a further 14 days (B2, B3); on day 41 after TGF␣ and then PBS infusion (B4); or on day 28 during infusion of PBS, TGF␣, TGF␣ϩnoggin, or noggin (B5). (C): Tam was administered to young adult nestin-CreER T2 /R26R-YFP mice daily between days 14 and 19 after 6-OHDA injection. (C1): The first group of mice was sacrificed 2 days after the end of Tam regimen. For the other two groups, pumps were implanted 1 week after the last Tam dose. Nestin-CreER T2 /R26R-YFP mice were sacrificed either on day 14 during TGF␣ or PBS infusion (C2) or on day 28 after infusion of PBS for a further 14-day period (C3). Abbreviations: 6-OHDA, 6-hydroxydopamine; BrdU, 5-bromo-2Ј-deoxyuridine; PBS, phosphatebuffered saline; SVZ, subventricular zone; Tam, tamoxifen; TGF␣, transforming growth factor ␣.
plantation before starting BrdU injections to avoid BrdU incorporation by reactive astroglia around the cannula site.
Histological Procedures
Animals were terminally anesthetized with sodium pentobarbital (100 mg/kg i.p.) and perfused with intracardial heparin saline (0.1% heparin in 0.9% saline; 100 ml per rat) and paraformaldehyde (4% in PBS; 200 ml per rat). The brains were postfixed and sectioned (40 m) as described [18] .
Immunohistochemistry
Routine indirect immunofluorescence was performed on randomly selected series of sections that represented 1/12th of the total brain [18] (primary antibody details are given in supplemental online Methods). For BrdU immunostaining, the sections were pretreated with 0.2% Triton X-100 for 2 hours and denatured with 2 N HCl for 40 minutes at 37°C. Primary antibodies were kept overnight at room temperature, except for EGFR, Mash1, and Dlx2 antibodies that were kept 48 -72 hours at 4°C. For double and triple labeling with BrdU, cell markers were detected before BrdU immunostaining. Primary antibodies were visualized using fluorescent secondary antibodies (Alexa Fluor; Molecular Probes, Eugene, OR, http:// probes.invitrogen.com). For EGFR, Mash1, and Dlx2 immunostainings, sections were treated for 2 hours at room temperature with a biotinylated secondary antibody (1:300; Jackson Laboratory, Bar Harbor, ME, http://www.jax.org) and then visualized using the tyramide signal amplification kit (TSA Plus System; PerkinElmer Life and Analytical Sciences, Waltham, MA, http://www. perkinelmer.com). Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) detected apoptosis-related DNA fragmentation using the manufacturer's protocol (Neurotacs II; R&D Systems).
Cell Counts
Cells were counted blind to experimental conditions. For striatal counts, a 100 -300-m-diameter circle with its center at the infusion site was excluded to avoid contamination of analyses by reactive astroglia. Sections were analyzed using either a standard microscope (BX51 [Olympus, Tokyo, http://www.olympus-global.com] or Axioskop 2ϩ [Carl Zeiss, Thornwood, NY, http://www.zeiss. com]) or a confocal microscope (LSM 510/Meta; Carl Zeiss). Cell counts and distances were measured using a stereology workstation (Stereoinvestigator; MicroBrightField Inc., Williston, VT, http:// www.mbfbioscience.com) with an integrated epifluorescence microscope (Axioskop 2ϩ; Carl Zeiss). BrdU ϩ cells colabeled with phenotypic markers were identified from orthogonal projections to confirm colocalization. For each marker and per animal, we analyzed 130 -280 BrdU ϩ cells per section on a total of four to six striatal sections spaced by 480 m (once every 12th section). For nestin expression, we identified high expression when signal was detectable using the following parameters on the confocal microscope: pinhole, 85 m; detector gain, 600; amplifier offset, Ϫ0.02 V. We considered nestin expression to be low when emission fluorescence was not detected using the above parameters but was detected using the following parameters: pinhole, 89 m; detector gain, 814; amplifier offset, Ϫ0.02 V.
Behavioral Testing
Unilaterally lesioned rats were tested for rotational behavior in response to amphetamine (4 mg/kg i.p.) before infusion and 3 days prior to sacrifice. Animals were randomized and placed into automated rotometer bowls, and left and right full-body turns were monitored by a computerized activity monitor system as described [18] .
Statistical Analysis
Data are presented as mean Ϯ SEM. One-way analysis of variance and Student's unpaired t test were used to assess differences between data groups using the JMP software (SAS Institute, Cary, NC, http://www.sas.com). Differences were considered statistically significant when p Ͻ .05.
RESULTS
Phenotypic Characterization of Newly Generated Cells in the DA-Depleted Striatum During TGF␣ Infusion
To determine the precise phenotype of the striatal nestin ϩ / PCNA ϩ cells in 6-OHDA-lesioned rats [2, 16] , we investigated NPC marker expression by BrdU ϩ cells in the ipsilateral striatum after 2 weeks of TGF␣ infusion (Fig. 1B1) . BrdU was injected throughout the infusion period to label cells that were in S-phase (Fig. 1B) . The majority (Ͼ 89%) of BrdU ϩ cells in the TGF␣-induced ipsilateral striatal and septal waves coexpressed nestin, EGFR, and Olig2, indicative of a "C-like" phenotype [13, 21] (supplemental online Fig. 1 ; Fig. 2A-2D, 2P ). We also found that 47% Ϯ 8% of the BrdU ϩ cells expressed Mash1 (Fig.  2E, 2P ), another marker of an SVZ C cell subpopulation [22] . Newborn cells in the TGF␣-activated contralateral, septal wave [2] and proliferative nodules also displayed this C-like cell phenotype (supplemental online Fig. 1 ). However, BrdU ϩ Clike cells in the waves differed from normal SVZ C cells in that they did not express Dlx2 (data not shown) [21] and had an elongated morphology (Fig. 2C ). Almost no BrdU ϩ cell in the striatum expressed the mature neural cell markers glial fibrillary acidic protein (GFAP), Tuj1, NeuN, CNPase, or Iba1 ( 
Distribution and Phenotypes of SVZ-Derived Cells After TGF␣ Withdrawal
Next, we examined the response of the C-like cells in the ipsilateral striatal wave after TGF␣ withdrawal. Unilaterally 6-OHDA-lesioned rats received TGF␣ for 2 weeks followed by a 2-week PBS infusion (Fig. 1B2 ). In these rats, the number of striatal PCNA ϩ dividing cells had markedly decreased compared with during TGF␣ infusion ( Fig. 3A-3C ), indicating that striatal mitotic activity was reduced. The number and distribution of BrdU ϩ cells in the ipsilateral striatum during or after TGF␣ infusion were also determined ( Fig. 3D-3G ). During TGF␣ infusion, BrdU ϩ cells were found in septal and striatal cellular waves (Fig. 3E) . After TGF␣ withdrawal, fewer BrdU ϩ cells remained in the striatal wave ( Fig. 3F) Fig. 3G ). This reduced number of newborn striatal cells was due, at least in part, to apoptotic mechanisms, because more TUNEL ϩ profiles were observed in the ipsilateral SVZ and striatum after TGF␣ withdrawal than in rats infused with PBS ( Fig. 3H-3K ; p Ͻ .05). Hypercellular nodules seen during TGF␣ infusion were virtually absent 2 weeks after TGF␣ withdrawal (Fig. 3E, 3F ), and their remnants were undergoing apoptotic cell death (Fig. 3J) . Importantly, the number of striatal BrdU ϩ cells was similar at 2 and 4 weeks post-TGF␣ (Figs. 1B4, 3G; 26,684 Ϯ 1,534 BrdU ϩ cells vs. 27,003 Ϯ 2,340 BrdU ϩ cells at 2 weeks and 4 weeks post-TGF␣ withdrawal, respectively), indicating that cell death was negligible from 2 weeks after TGF␣ withdrawal.
Next we investigated the phenotype(s) of the remaining ϳ28,000 BrdU ϩ striatal wave cells per rat (Fig. 4A ), 2 weeks after TGF␣ pump withdrawal. The majority of these BrdU ϩ cells (Ͼ92%; Fig. 4E ) did not express Olig2, Mash1, or EGFR ( Fig. 4B ; data not shown), indicating that the C-like cells had differentiated. However, 79% Ϯ 8% of BrdU ϩ striatal cells still expressed nestin, although to a lower level than during TGF␣ infusion (compare Fig. 4B, 4C with Fig. 2B, 2C ; Materials and Methods). These data demonstrate that TGF␣ withdrawal did not result in full differentiation of many SVZ-derived striatal cells by 2 weeks. Importantly, however, we found that 35% Ϯ 4% of striatal BrdU ϩ cells were GFAP ϩ astrocytes (Fig. 4D,  4E ), 70% Ϯ 10% of which coexpressed low levels of nestin (data not shown). These BrdU ϩ /GFAP ϩ astrocytes did not express SSEA-1 or PCNA (data not shown), suggesting that they were postmitotic cells and not B-like cells. Importantly, 540 Ϯ 12 BrdU ϩ cells per DA-depleted striatum coexpressed DCX, PSANCAM, and nestin (demonstrated using staining on adjacent sections); this amount represented ϳ2% of the striatal BrdU ϩ population (Fig. 4F, 4G ). In contrast, the number of ectopic striatal DCX ϩ neuroblasts was approximately 15 times larger (7,606 Ϯ 2,131 cells per ipsilateral striatum; Fig. 4H , 
4M). Striatal DCX
ϩ /PSANCAM ϩ cells were proliferating after TGF␣ withdrawal, because 82% Ϯ 6% of them expressed the endogenous proliferation marker PCNA (Fig. 4I) . Therefore, the absence of BrdU labeling in ectopic striatal neuroblasts was probably due to BrdU dilution following a large number of divisions during the 2-week PBS infusion period (i.e., "washing period") post-TGF␣ withdrawal. Seventy-five percent of such DCX ϩ cells expressed Tuj1 (Fig. 4J) , confirming a neuroblast phenotype. However, none of the DCX ϩ or PSANCAM ϩ cells in the striatum expressed Pax6, whereas SVZ neuroblasts were Pax6 ϩ in the same tissue section (data not shown). Interestingly, most ectopic striatal neuroblasts formed clusters that were in close contact with GFAP ϩ processes of astrocytes that had their end feet on blood vessels (Fig. 4K, 4L) .
ϩ microglial cells at this time (1.5% Ϯ 2%; Fig. 4E ). Finally, we found similar phenotypes of BrdUϩ cells at 4 weeks post-TGF␣-withdrawal (data not shown). Strikingly, however, the number of PSANCAM ϩ neuroblasts was increased at this later time point ( Fig. 4M ; supplemental online Fig. 2 
Distribution and Phenotypes of SVZ-Derived Cells After TGF␣ Followed by Noggin Infusions
In an attempt to block astroglial differentiation and to enhance neuronal differentiation of TGF␣-stimulated cells in the DA-depleted striatum, we used the bone morphogenetic protein (BMP) antagonist noggin [23] . Noggin was first infused alone in the rat DA-depleted striatum for 4 weeks, to verify previous data indicating that noggin was proneuronal for SVZ NPCs in vivo [17] . Interestingly, noggin expanded the PSANCAM ϩ neuroblast population in the ipsilateral SVZ, compared with PBS infusion (358 Ϯ 33 cells vs. 238 Ϯ 15 cells per SVZ section for noggin-infused and PBS-infused rats, respectively; unpaired t-test; p Ͻ .01; Fig. 5A , 5B). Importantly, noggin infusion did not alter the number of nestin ϩ /PCNA ϩ NPCs in the ipsilateral SVZ or striatum, relative to PBS administration alone (Fig. 5C, 5D ), indicating that proliferation, migration, and survival of NPCs were unaltered. These data demonstrate diffusion over long distances and the induction of a proneuronal effect on SVZ cells by noggin.
To test the effect of noggin on TGF␣-activated BrdU ϩ cells recruited in the striatum, rats were administered TGF␣ for 2 weeks, followed by 2 weeks of noggin infusion (Fig. 1B3) . The total number of striatal BrdU ϩ cells was unchanged compared with rats with TGF␣/PBS sequential infusions (compare Fig. 5E 
/GFAP
ϩ astrocytes in the DA-depleted striatum (Fig. 5F , 5H, 5I; 3% Ϯ 1% vs. 35% Ϯ 4% of astrocytes among new cells for TGF␣/noggin sequential infusion and TGF␣/PBS sequential infusion, respectively; unpaired t test; p Ͻ .01). In contrast, neuronal commitment, as measured by DCX expression, was unchanged compared with TGF␣/PBS sequentially infused rats ( Fig. 5H, 5J ) tended to increase compared with TGF␣/PBS sequentially infused rats ( Fig. 5G, 5H ; p ϭ .079), suggesting that BrdU ϩ cells that did not differentiate into astrocytes stayed in a nestin ϩ immature state rather than differentiating.
We also determined the effect of TGF␣ and noggin coinfusion for 4 weeks (Fig. 1B5) . In this condition, most BrdU ϩ striatal cells were EGFR ϩ /Olig2 ϩ /nestin ϩ C-like cells (supplemental online Fig. 2) , which was similar to the TGF␣-only condition. These data show that the TGF␣ effect was predominant and blocked the noggin effect.
Nestin-CreER T2 /R26R-YFP Mice Demonstrate That TGF␣-Induced Striatal Cells Originate from SVZ Nestin ؉ Precursors
An important basic biological question was to determine whether the striatal wave of C-like cells observed during TGF␣ infusion originated from nestin ϩ SVZ precursors. For this purpose, we used inducible nestin-CreER T2 /R26R-YFP mice. Upon tamoxifen administration, YFP expression in SVZ and SGZ precursors [19] allows genetic fate-mapping of adult neurogenesis. We administered tamoxifen to 5-8 week-old transgenic mice that had received a unilateral 6-OHDA injection 2 weeks before (Fig. 1C) . Two days after tamoxifen treatment (Fig. 1C1) , YFP ϩ cells were only observed in the SVZ, RMS, and dentate gyrus of hippocampus (data not shown). In mice sacrificed during PBS infusion (Fig. 1C2) , forebrain YFP ϩ cells were restricted to the same regions, except that their distribution had changed, with many YFP ϩ cells in the OB (Fig. 6A) . In contrast, in mice sacrificed during TGF␣ infusion (Fig. 1C2) , YFP ϩ SVZ cells had expanded and colonized the ipsilateral medial striatum, septum, corpus callosum, and deep layers of the neocortex (Fig. 6B) . The majority of these YFP ϩ cells expressed nestin and PCNA (Fig. 6C) , as well as BrdU (Fig. 6D) . These data unambiguously show that the striatal nestin ϩ /PCNA ϩ precursors described by Cooper and Isacson [2] originated from SVZ nestin ϩ precursors. They also indicate that tamoxifen did not substantially interfere with TGF␣ signaling [24] . YFP cells did not express GFAP at this time (Fig. 6E) , indicating that we were not measuring reactive gliosis at this point.
The C-like cell phenotype of ectopic striatal YFP ϩ SVZ cell progeny was confirmed by coexpression with EGFR and Olig2 (Fig. 6F, 6G) . The transgenic mouse model also allowed us to determine the fine morphology of striatal C-like cells:
ϩ cells had a complex morphology, with numerous processes oriented toward the source of TGF␣ (Fig. 6C, 6G) .
Two weeks after TGF␣ withdrawal (Fig. 1C3) , we observed a decrease in striatal, septal, and olfactory bulb YFP ϩ cells, as well as a dispersion of YFP ϩ cells in the ipsilateral striatum (compare Fig. 6H with Fig. 6B) , which corroborated the rat data. Also, examining the fate of YFP ϩ cells in nestin-CreER T2 / R26R-YFP mice 2 weeks after TGF␣ pump withdrawal showed that some striatal YFP ϩ cells were GFAP ϩ astrocytes, whereas others were PSANCAM ϩ neuroblasts (Fig. 6I, 6J ), again confirming the rat data. We also observed striatal YFP ϩ cells that were nestin ϩ /GFAP Ϫ /PSANCAM Ϫ undifferentiated cells, with a morphology reminiscent of astrocytes (data not shown).
Differential Fate of Striatal and Olfactory Bulb C-Like Cells After TGF␣ Withdrawal
In the olfactory bulb of 6-OHDA-lesioned nestin-CreER T2 /R26R-YFP mice during PBS infusion, YFP ϩ cells were either granular or periglomerular interneurons (data not shown), consistent with the normal fate of SVZ NPCs [25] . In contrast, TGF␣ infusion generated olfactory bulb YFP
ϩ cells, reminiscent of the C-like phenotype observed in the striatum (Fig. 7A-7C ). The number of YFP ϩ cells in the olfactory bulb was also greatly enhanced by TGF␣ infusion (compare Fig. 6A with Fig. 6B ). Importantly, upon TGF␣ withdrawal, most YFP ϩ cells were granular or periglomerular interneurons (NeuN expression with typical neuronal morphology; Fig. 7D, 7E ) and were much more numerous than during PBS infusion (supplemental online Fig. 3 ). This indicates that olfactory bulb C-like cells, as opposed to their striatal counterparts, had differentiated into mature neurons in the olfactory bulb upon TGF␣ withdrawal, thus highlighting a decisive influence of the microenvironment-striatal versus bulbar-on the fate of the C-like cells.
Absence of New TH ؉ Neurons and Behavioral Improvement
The ability of TGF␣, noggin, or TGF␣ and noggin intrastriatal coinfusion/sequential infusions to restore motor function in rat groups with a unilateral 6-OHDA lesion was examined. Amphetamine-induced rotations were counted before and after the 2-4-week infusion period [26] . No significant reductions in rotation scores for any infusion groups were found (supplemental online Fig. 4) . Consistent with these findings, not a single TH ϩ cell that had incorporated BrdU or YFP was seen in the DA-depleted striatum in all rat and mouse groups, respectively (data not shown).
DISCUSSION
In this study, we first characterized the phenotype of striatal nestin ϩ /PCNA ϩ cells generated by TGF␣ infusion in the rat DA-depleted striatum [2] . These BrdU ϩ cells coexpressed Olig2, EGFR, nestin, and Mash1, consistent with the phenotype of multipotent C cells [21] . Second, we determined the fate of ϭ 50 m (A, G) , 100 m (C, E), and 25 m (F). Abbreviations: BrdU, 5-bromo-2Ј-deoxyuridine; CC, corpus callosum; DAPI, 4,6-diamidino-2-phenylindole; DCX, doublecortin; EGFR, epidermal growth factor receptor; GFAP, glial fibrillary acidic protein; PBS, phosphate-buffered saline; PCNA, proliferating cell nuclear antigen; PSANCAM, polysialylated neuronal cell adhesion molecule; SVZ, subventricular zone; TGF␣, transforming growth factor ␣; TGFa, transforming growth factor ␣.
these cells upon TGF␣ withdrawal. We observed large numbers of new striatal neuroblasts and astrocytes, confirming the in vivo multipotency of the striatal C-like cells, whereas some nestin ϩ SVZ-derived striatal cells remained undifferentiated at this stage. Third, we increased the neuroblast-to-astrocyte ratio in the DA-depleted striatum by administering the BMP antagonist noggin after TGF␣ withdrawal. Interestingly, in our 2-week infusion paradigm, noggin treatment blocked glial differentiation, but neuroblast differentiation was not increased. Finally, using nestin-CreER T2 /R26R-YFP mice, we showed that striatal neurogenic C-like cells originate from the SVZ and confirmed the phenotype and neuronal/glial fate of such rat cells after TGF␣ withdrawal. We also determined that, in contrast to their striatal counterparts, olfactory bulb C-like cells give rise to . Abbreviations: contra, contralateral; GFAP, glial fibrillary acidic protein; ipsi, ipsilateral; OB, olfactory bulb; PBS, phosphate-buffered saline; PCNA, proliferating cell nuclear antigen; PSANCAM, polysialylated neuronal cell adhesion molecule; SVZ, subventricular zone; TGF␣, transforming growth factor ␣. mature neurons, emphasizing an environmental effect on the fate of C-like cells. The generation of a large number of NPCs with neurogenic potential in the DA-depleted striatum is of therapeutic interest, and our evidence suggests that such C-like cells require additional midbrain or forebrain cues [13, [27] [28] [29] to differentiate into mature DA neurons suitable to improve function in PD. A longer period postinfusion may also be required to completely understand the differentiation potential of these newly generated cells.
Phenotype of SVZ-Derived Cells and Striatal Response During TGF␣ Infusion
In vivo, EGFR ligands increase C cell proliferation and colonization of the striatum by their cellular progeny [2, 21] . However, the progeny phenotype of these striatal C cells has not been determined, making it difficult to determine whether such cells can be directed for neural repair in PD. In this study, we found that during TGF␣ infusion, most SVZ-derived cells recruited to the striatum displayed features of C cells, such as Olig2, nestin, EGFR, and Mash1 expression [2, 8, 13, 16, 21, 22] . However, such cells were different from SVZ C cells because they had an elongated and complex morphology (whereas SVZ C cells have a simple, globular morphology), expressed nestin more strongly, and did not express Dlx2 [7, 21] .
TGF␣-induced striatal C-like cells expressed markers of mitotic activity (i.e., BrdU and PCNA), as well as ␤-catenin, EGFR, and Olig2, which are known markers of SVZ C cells and glioma-forming cells [30 -33] . Hence, our data emphasize the roles of EGFR signaling, the Wnt/␤-catenin signaling pathway, and the transcriptional repressor activity of Olig2 in inducing adult NPCs to adopt a high replication state.
Another novel finding in this field is that TGF␣ infusion elevated the number of microglial cells in both ipsilateral SVZ and striatum. This was not due to a direct mitogenic effect of TGF␣ on microglia, since they rarely incorporated BrdU (2% Ϯ 3%). Rather, existing microglia were probably recruited from other brain regions [34, 35] . Such microglial recruitment toward the region of cell proliferation was not likely due to a direct action of TGF␣, since TGF␣ overexpression in transgenic mice does not modify microglia number or behavior [36] . Instead, microglial cells may have been attracted by signals released by cells undergoing apoptosis, as discussed below. Recent reports indicate that microglia influence adult neurogenesis [37] [38] [39] [40] . For example, microglia activated by cytokines associated with T-helper cells may stimulate neurogenesis [41] , whereas inflammation-associated microglia reduce neurogenesis [42, 43] . Whether the microglia affected neurogenesis in the present paradigm remains to be elucidated.
TGF␣ Withdrawal Induces a Large Population of Neuroblasts in the DA-Depleted Striatum
In the second phase of the investigation, we examined the effect of TGF␣ withdrawal on the fate of striatal C-like cells. Two weeks after TGF␣ withdrawal, ϳ34% fewer BrdU ϩ cells were present. This was at least partly due to apoptotic cell death, because TUNEL ϩ cells were found in the striatal cellular wave. The surviving new cells in the striatum were composed of GFAP ϩ astrocytes, DCX ϩ /PSANCAM ϩ /nestin ϩ neuroblasts, and immature cells that expressed nestin and/or PCNA only. The BrdU ϩ /GFAP ϩ astrocytes often expressed low levels of nestin but did not express SSEA-1 or PCNA. Therefore, these cells likely represent an immature astrocyte population rather than B-like "neural stem" cells [44] . Among the striatal neuroblast population, ϳ82% of the cells expressed PCNA, whereas only ϳ7% expressed BrdU. This, along with YFP/PSANCAM coexpression in the striatum of nestin-CreER T2 /R26R-YFP mice, is consistent with the progressive loss of BrdU by dilution over numerous cell divisions [45] . Because PCNA was almost restricted to DCX ϩ cells 2 weeks after TGF␣ withdrawal, any disappearance of BrdU by dilution is likely to have preferentially affected this population. The absence of YFP ϩ /NeuN ϩ cells in the DA-depleted striatum of nestin-CreER T2 /R26R-YFP mice indicates that mature neurons were not generated by TGF␣ in this region.
Another surprising finding was that, in contrast to SVZ and RMS neuroblasts, ectopic striatal neuroblasts did not express the transcription factor Pax6. This difference suggests that ectopic striatal neuroblasts would differentiate into olfactory bulb GABAergic interneurons, rather than A16 DA neurons, without further stimulation [13, 14] .
We also observed the presence of newly generated neuroblast clusters along blood vessels and in contact with astrocytes, similar to their normal SVZ niche [5] . The astrocytes surround- ing the neuroblast clusters likely did not arise from the SVZ given the absence of BrdU, PCNA, or nestin coexpression.
Besides the astrocyte and neuroblast populations, the majority of remaining striatal BrdU ϩ cells were immature because they expressed nestin, without Olig2, EGFR, or Mash1 expression at this time. The long-term fate of those BrdU ϩ /nestin ϩ cells is uncertain: they may retain an immature phenotype or ultimately differentiate or die because of lack of fate specification and/or trophic supply. Interestingly, no BrdU ϩ cells in the striatum were CNPase ϩ , O4 ϩ oligodendrocytes. This result was surprising because, in the presence of TGF␣, a high proportion of BrdU ϩ cells expressed Olig2 and Mash1, which are transcription factors involved in oligodendrocyte specification in the embryo and postnatal SVZ [46, 47] . Nevertheless, the absence of NG2 expression by the Olig2 ϩ /Mash1 ϩ cells confirmed that they were not typical oligodendrocyte precursors [48] . A recent study using CNP-hEGFR-overexpressing mice indicates that EGFR signaling activation is involved in oligodendrogenesis and remyelination in demyelinating conditions [49] . Therefore, it is possible that such demyelinating conditions are required for TGF␣-activated NPCs to undergo oligodendrogenesis [50] .
Effects of TGF␣ and Noggin Sequential Infusions on the Striatal Neuroblast-to-Astrocyte Ratio
We examined whether administration of the BMP antagonist noggin after TGF␣ withdrawal would influence the neuroblastto-astrocyte ratio by blocking gliogenesis and/or inducing neurogenesis [51] . We found that striatal infusion of noggin without TGF␣ in 6-OHDA-lesioned rats significantly increased SVZ neurogenesis. This is in line with published data [17] and demonstrates that the noggin protein diffuses over long distances (approximately 2.7 mm) and remains functional when chronically infused in vivo. In contrast to SVZ, the normal striatum is gliogenic for SVZ cells [52] , probably because noggin and other BMP antagonists are at negligible levels [53] . However, virally delivered noggin reverses this effect and induces neurogenesis from SVZ cells recruited to the striatum, either after transplantation or following BDNF-induced recruitment [17, 54] . Strikingly, in our in vivo DA depletion paradigm, noggin did not increase striatal neurogenesis but only blocked gliogenesis. This difference with previous literature [17, 54] may be due to paradigm differences. The present data suggest that noggin is primarily antigliogenic, whereas other factors confined to SVZ induce neurogenesis when gliogenesis is blocked.
Comparisons with Other Paradigms Inducing Adult SVZ Neurogenesis
As mentioned, we found ϳ8,000 newly generated striatal neuroblasts 2 weeks after the EGFR ligand withdrawal. This cell number is similar to that found by Arvidsson et al. [55] 2 weeks after striatal stroke induction (6,312 DCX ϩ neuroblasts), but it is ϳ4 times larger than the 1,600 BrdU ϩ /Tuj1 ϩ cells found after adenoviral coadministration of BDNF and noggin [54] . In our paradigm, striatal neuroblasts formed tight clusters throughout the medial striatum, whereas they were individualized in the studies from Arvidsson et al. [55] and Chmielnicki et al. [54] . Furthermore, in our paradigm, 82% of neuroblasts continued to divide 2 weeks after growth factor withdrawal, but this remains unknown in the other paradigms [54, 55] .
There are both analogies and differences between our in vivo paradigm and published in vitro neurosphere culture assays [56] . In neurosphere cultures, SVZ cells grow as clonal spheres in the presence of epidermal growth factor (EGF) [57] . Notably, neurosphere cells rapidly upregulate Olig2 and downregulate Pax6 in these proliferative conditions [58] , and withdrawing EGF is required for differentiation into neurons and glia after plating [21] , as shown here in vivo. However, the fact that SVZ cells did not differentiate into oligodendrocytes in vivo in the present study, whereas some do in vitro [56] , suggests that the striatal microenvironment influences the fate of SVZ cells.
CONCLUSION
We demonstrated that striatal TGF␣ infusion recruits a large population of SVZ-derived multipotent C-like cells to the DAdepleted striatum. After TGF␣ withdrawal, astrocytes, neuroblasts, and undifferentiated cells, but not oligodendrocytes or differentiated neurons, are generated. Noggin infusion after TGF␣ blocks astrocyte generation in favor of an undifferentiated phenotype, thus increasing the neuroblast-to-astrocyte ratio.
